Intravitreal ranibizumab for choroidal neovascularisation secondary to pathologic myopia: 12 month results
Gespeichert in:
| Veröffentlicht in: | Eye (London) 2010-08, Vol.24 (8), p.1420-1420 |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1420 |
|---|---|
| container_issue | 8 |
| container_start_page | 1420 |
| container_title | Eye (London) |
| container_volume | 24 |
| creator | Rajendram, R Costa-Gomes, N Horgan, S E |
| description | |
| doi_str_mv | 10.1038/eye.2010.40 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_748942163</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>748942163</sourcerecordid><originalsourceid>FETCH-LOGICAL-c347t-8a3663705cc12f7017db98f5c661c67d9b8f396fc5192732ae7e4e0f6de7e7a83</originalsourceid><addsrcrecordid>eNptkc1LwzAYxoMobk5P3iV48aCd-WrSepPhx2DgRcFbSdN0y2ibmaSD-debsakgnt68PD-e5MkDwDlGY4xodqs3ekxQ3Bg6AEPMBE9SlrJDMER5ihJCyPsAnHi_RCiKAh2DAUGMYo7pECynXXBybYLTsoFOdqY0n30rS1hbB9XCOmuqqHTarqVXfSOd8TIY20Gvle0q6TYwWLiSYWEbOzcKthu7MvIOYgJb24UFdNr3TfCn4KiWjddn-zkCb48Pr5PnZPbyNJ3czxJFmQhJJinnVKBUKUxqgbCoyjyrU8U5VlxUeZnVNOe1SnFOBCVSC800qnkVD0JmdASudr4rZz967UPRGq9008gYoveFYFnOCOY0kpd_yKXtXRcfFyGS4iwnaYSud5By1nun62LlTBtjFxgV2wKKWECxLaBgKNIXe8u-bHX1w37_eARudoCPUjfX7vfO__y-AGZGkSg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>742518925</pqid></control><display><type>article</type><title>Intravitreal ranibizumab for choroidal neovascularisation secondary to pathologic myopia: 12 month results</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><source>SpringerLink Journals - AutoHoldings</source><creator>Rajendram, R ; Costa-Gomes, N ; Horgan, S E</creator><creatorcontrib>Rajendram, R ; Costa-Gomes, N ; Horgan, S E</creatorcontrib><identifier>ISSN: 0950-222X</identifier><identifier>EISSN: 1476-5454</identifier><identifier>DOI: 10.1038/eye.2010.40</identifier><identifier>PMID: 20431613</identifier><language>eng</language><publisher>London: Nature Publishing Group UK</publisher><subject>692/700/565/1436 ; Age Factors ; Aged ; Antibodies, Monoclonal - therapeutic use ; Antibodies, Monoclonal, Humanized ; Choroidal Neovascularization - drug therapy ; Choroidal Neovascularization - etiology ; correspondence ; Humans ; Immunologic Factors - therapeutic use ; Intravitreal Injections ; Laboratory Medicine ; Medicine ; Medicine & Public Health ; Myopia - complications ; Myopia - diagnosis ; Ophthalmology ; Pharmaceutical Sciences/Technology ; Ranibizumab ; Surgery ; Surgical Oncology</subject><ispartof>Eye (London), 2010-08, Vol.24 (8), p.1420-1420</ispartof><rights>Royal College of Ophthalmologists 2010</rights><rights>Copyright Nature Publishing Group Aug 2010</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c347t-8a3663705cc12f7017db98f5c661c67d9b8f396fc5192732ae7e4e0f6de7e7a83</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1038/eye.2010.40$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1038/eye.2010.40$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,776,780,27901,27902,41464,42533,51294</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20431613$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Rajendram, R</creatorcontrib><creatorcontrib>Costa-Gomes, N</creatorcontrib><creatorcontrib>Horgan, S E</creatorcontrib><title>Intravitreal ranibizumab for choroidal neovascularisation secondary to pathologic myopia: 12 month results</title><title>Eye (London)</title><addtitle>Eye</addtitle><addtitle>Eye (Lond)</addtitle><subject>692/700/565/1436</subject><subject>Age Factors</subject><subject>Aged</subject><subject>Antibodies, Monoclonal - therapeutic use</subject><subject>Antibodies, Monoclonal, Humanized</subject><subject>Choroidal Neovascularization - drug therapy</subject><subject>Choroidal Neovascularization - etiology</subject><subject>correspondence</subject><subject>Humans</subject><subject>Immunologic Factors - therapeutic use</subject><subject>Intravitreal Injections</subject><subject>Laboratory Medicine</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Myopia - complications</subject><subject>Myopia - diagnosis</subject><subject>Ophthalmology</subject><subject>Pharmaceutical Sciences/Technology</subject><subject>Ranibizumab</subject><subject>Surgery</subject><subject>Surgical Oncology</subject><issn>0950-222X</issn><issn>1476-5454</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNptkc1LwzAYxoMobk5P3iV48aCd-WrSepPhx2DgRcFbSdN0y2ibmaSD-debsakgnt68PD-e5MkDwDlGY4xodqs3ekxQ3Bg6AEPMBE9SlrJDMER5ihJCyPsAnHi_RCiKAh2DAUGMYo7pECynXXBybYLTsoFOdqY0n30rS1hbB9XCOmuqqHTarqVXfSOd8TIY20Gvle0q6TYwWLiSYWEbOzcKthu7MvIOYgJb24UFdNr3TfCn4KiWjddn-zkCb48Pr5PnZPbyNJ3czxJFmQhJJinnVKBUKUxqgbCoyjyrU8U5VlxUeZnVNOe1SnFOBCVSC800qnkVD0JmdASudr4rZz967UPRGq9008gYoveFYFnOCOY0kpd_yKXtXRcfFyGS4iwnaYSud5By1nun62LlTBtjFxgV2wKKWECxLaBgKNIXe8u-bHX1w37_eARudoCPUjfX7vfO__y-AGZGkSg</recordid><startdate>20100801</startdate><enddate>20100801</enddate><creator>Rajendram, R</creator><creator>Costa-Gomes, N</creator><creator>Horgan, S E</creator><general>Nature Publishing Group UK</general><general>Nature Publishing Group</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7TK</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>7X8</scope></search><sort><creationdate>20100801</creationdate><title>Intravitreal ranibizumab for choroidal neovascularisation secondary to pathologic myopia: 12 month results</title><author>Rajendram, R ; Costa-Gomes, N ; Horgan, S E</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c347t-8a3663705cc12f7017db98f5c661c67d9b8f396fc5192732ae7e4e0f6de7e7a83</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>692/700/565/1436</topic><topic>Age Factors</topic><topic>Aged</topic><topic>Antibodies, Monoclonal - therapeutic use</topic><topic>Antibodies, Monoclonal, Humanized</topic><topic>Choroidal Neovascularization - drug therapy</topic><topic>Choroidal Neovascularization - etiology</topic><topic>correspondence</topic><topic>Humans</topic><topic>Immunologic Factors - therapeutic use</topic><topic>Intravitreal Injections</topic><topic>Laboratory Medicine</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Myopia - complications</topic><topic>Myopia - diagnosis</topic><topic>Ophthalmology</topic><topic>Pharmaceutical Sciences/Technology</topic><topic>Ranibizumab</topic><topic>Surgery</topic><topic>Surgical Oncology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Rajendram, R</creatorcontrib><creatorcontrib>Costa-Gomes, N</creatorcontrib><creatorcontrib>Horgan, S E</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Neurosciences Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Biological Science Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>MEDLINE - Academic</collection><jtitle>Eye (London)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Rajendram, R</au><au>Costa-Gomes, N</au><au>Horgan, S E</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Intravitreal ranibizumab for choroidal neovascularisation secondary to pathologic myopia: 12 month results</atitle><jtitle>Eye (London)</jtitle><stitle>Eye</stitle><addtitle>Eye (Lond)</addtitle><date>2010-08-01</date><risdate>2010</risdate><volume>24</volume><issue>8</issue><spage>1420</spage><epage>1420</epage><pages>1420-1420</pages><issn>0950-222X</issn><eissn>1476-5454</eissn><cop>London</cop><pub>Nature Publishing Group UK</pub><pmid>20431613</pmid><doi>10.1038/eye.2010.40</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0950-222X |
| ispartof | Eye (London), 2010-08, Vol.24 (8), p.1420-1420 |
| issn | 0950-222X 1476-5454 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_748942163 |
| source | MEDLINE; EZB-FREE-00999 freely available EZB journals; SpringerLink Journals - AutoHoldings |
| subjects | 692/700/565/1436 Age Factors Aged Antibodies, Monoclonal - therapeutic use Antibodies, Monoclonal, Humanized Choroidal Neovascularization - drug therapy Choroidal Neovascularization - etiology correspondence Humans Immunologic Factors - therapeutic use Intravitreal Injections Laboratory Medicine Medicine Medicine & Public Health Myopia - complications Myopia - diagnosis Ophthalmology Pharmaceutical Sciences/Technology Ranibizumab Surgery Surgical Oncology |
| title | Intravitreal ranibizumab for choroidal neovascularisation secondary to pathologic myopia: 12 month results |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-29T03%3A56%3A48IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Intravitreal%20ranibizumab%20for%20choroidal%20neovascularisation%20secondary%20to%20pathologic%20myopia:%2012%20month%20results&rft.jtitle=Eye%20(London)&rft.au=Rajendram,%20R&rft.date=2010-08-01&rft.volume=24&rft.issue=8&rft.spage=1420&rft.epage=1420&rft.pages=1420-1420&rft.issn=0950-222X&rft.eissn=1476-5454&rft_id=info:doi/10.1038/eye.2010.40&rft_dat=%3Cproquest_cross%3E748942163%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=742518925&rft_id=info:pmid/20431613&rfr_iscdi=true |